PATENT CLAIM ANALYSIS

Application Number: 16098288
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["424", "133100"]

Abstract:
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.

Claim (Index 2):
The compound of  claim 1  that is a compound of formula I.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.24324
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16098260', '16098239', '16098257', '14933863', '14933879']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7578866059718914
- 35 USC 102 Novelty (BERT): 0.5685427400757818
- Combined Prediction Score: 0.7389522193822804
- Mean Citation Score: 390.402226
- Max Citation Score: 427.52084
- Similarity Product: 423.9986864731694

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test